The Pre-Meeting Intel Brief

Why this tool?

This is a perfect fit for Claude Desktop running Sonnet: a one-off workflow, with tool use, multiple steps, and detailed output. If you're doing additional research, use Cowork for planning and tracked tasks. Either is great.

Step-by-step workflow

1. 01

   Gather contact name, title and company
2. 02

   Construct short, 1 - 2 sentence on the meeting objective for context. This should explain your objective, and the product, service, or outcome that is the focus of the engagement.
3. 03

   Replace the placeholders in the prompt.
4. 04

   Before submitting the prompt, ensure that webfetch and/or browser control features are enabled in Claude settings.
5. 05

   Execute the prompt.
6. 06

   Optional - Ask Claude to save the outcome to a document for sharing and safekeeping. You can specifically ask for a word doc, markdown, or PDF

Example prompts

I have an initial pitch Meeting with Adam Weinroth, CMOat Form Bio on March 24th.

My context: I'm showcasing my agentic marketing platform for small marketing teams and agencies. 

Research this person and company and give me a pre-meeting intel brief with these sections:

1. PERSON — Background, career arc, how long in current role, anything notable

2. COMPANY — What they do, size/stage, recent news or shifts

3. THEIR WORLD — Likely priorities, pressures, or pain points relevant to my context

4. TECH & TOOLS — Any known stack signals relevant to my context (optional if not applicable)

5. QUESTIONS TO ASK — 4-5 specific, non-generic questions worth raising

6. WATCH OUTS — Anything to avoid, tread carefully around, or not assume

Keep each section tight. I need this fast, not exhaustive.

What to expect

Here's your pre-meeting intel brief for **March 24th — Adam Weinroth, CMO @ Form Bio**. --- ## PRE-MEETING INTEL BRIEF **Adam Weinroth | CMO, Form Bio | March 24, 2026** *Context: Showcasing agentic marketing platform for small marketing teams / agencies* --- ### 1. PERSON Adam built Form Bio's marketing function from the ground up as part of the 2022 spinout from Colossal Biosciences and $30M fundraise — full board-facing responsibility, built the team and agency ecosystem from scratch. Before that, he was CMO at Invoiced (now part of Flywire), where he sourced 100% of sales pipeline and landed customers including MassMutual, Berkshire Hathaway, and T-Mobile. He has roughly 28+ years of marketing experience spanning product marketing, digital, lead gen, and social. Texas McCombs undergrad (BBA) and MBA. He's been in the CMO seat at Form Bio since 2022 — so roughly 3-4 years in role. **Notable:** He also runs **anthro.marketing**, a community platform for marketers — you contributed recipes there. That's a warm entry point worth referencing. --- ### 2. COMPANY Form Bio is the first spinout of Colossal Biosciences, the $10B+ synthetic biology company known for de-extinction work. Form delivers AI-powered solutions to biopharma companies, accelerating drug development for complex therapeutic areas like genetic medicine, with proprietary LLMs trained on over 3 trillion nucleotides. They raised $30M total (Series A), are headquartered in Austin, and have approximately 42 employees. There was a significant leadership shift in October 2025 — a new CEO came in to succeed co-founders Andrew Busey and Kent Wakeford, framed as accelerating "the next phase of AI-powered growth." That transition likely reshuffled internal priorities. Recent partnerships include Azenta/GENEWIZ for AAV gene therapy development and ongoing work with Google and NVIDIA. --- ### 3. THEIR WORLD Adam is running marketing for a ~42-person deep-tech company in a highly specialized niche (AAV/gene therapy). His pressures are predictable and acute: - **Tiny team, massive scope.** He's covering demand gen, product marketing, brand/comms, partner marketing, and category creation simultaneously. There's no big team absorbing this. - **Scientific audience problem.** He's navigating content creation and distribution for a highly technical, skeptical scientific audience — generic AI content won't fly. - **New CEO = reset moment.** Leadership change in late 2025 means he's likely re-proving his strategy upward and may be open to tools that show efficiency and ROI quickly. - **AI-forward mindset.** He's publicly stated that marketers not already using AI are falling behind — he's receptive, not resistant. --- ### 4. TECH & TOOLS He uses Pitchfire for all vendor communication — meaning he's intentionally managing his vendor inbox. He set up this meeting through a deliberate channel, so he's a structured, selective buyer. His stack likely includes HubSpot or Salesforce for CRM (common at this stage/size), and he's shown comfort with ABM tools given his demand gen approach. His content infrastructure includes the AAV Resource Hub, events, email, advertising, and partnership marketing — distributed, multi-channel. --- ### 5. QUESTIONS TO ASK 1. **"You built the marketing function from zero at Form Bio — where are the biggest gaps now that you're trying to scale?"** Gets him talking about current state before you pitch anything. 2. **"With the CEO transition, how has marketing's mandate shifted heading into this year?"** Opens the door to understanding if priorities have changed and where he needs to show value fast. 3. **"You've built a lot of category infrastructure — the AAV Resource Hub, the working groups — how are you thinking about operationalizing that content into pipeline?"** Shows you did your homework; connects to your platform's value. 4. **"For a team your size covering the scope you cover, where does the most time get wasted that you wish could just run?"** Perfect setup to position agentic automation. 5. **"You're also running anthro.marketing alongside this role — how are you thinking about what you're building there?"** Personal rapport, shows you know him beyond the day job. --- ### 6. WATCH OUTS - **Don't lead with "AI automation."** He lives in an AI company — that's table stakes, not a differentiator. Lead with the *leverage* story: more output, tighter team, faster pipeline. - **Don't assume budget flexibility.** At $30M raised and 42 people, they're lean. Frame ROI in time saved and output produced, not features. - **Don't conflate Form Bio with Formation Bio.** They're completely different companies (Formation Bio is a separate AI drug discovery firm). Easy mixup, bad look. - **New CEO is sensitive territory.** You don't know the internal dynamics post-transition. Don't speculate or probe too hard — but do listen for signals. - **He's a structured vendor manager (Pitchfire).** He runs a tight meeting. Come with a clear POV, not a product tour. --- Good luck Monday. The anthro.marketing connection is your best warm opener — use it early.